Luisa Riancho Selected Research

Benzalkonium Compounds (Benzalkonium Chloride)

6/2017	Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma.
1/2017	Hyperosmolarity and Benzalkonium Chloride Differently Stimulate Inflammatory Markers in Conjunctiva-Derived Epithelial Cells in vitro.
1/2015	Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments.
1/2012	Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro.
9/2007	In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa Riancho Research Topics

Disease

3	Glaucoma 06/2017 - 01/2008
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2017 - 01/2012
2	Inflammation (Inflammations) 06/2011 - 01/2008
1	Edema (Dropsy) 03/2022
1	Gliosis 03/2022
1	Epiretinal Membrane (Epiretinal Membranes) 03/2022
1	Infections 02/2020
1	Ocular Hypertension (Glaucoma, Suspect) 09/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2015
1	Herpes Zoster 06/2011
1	Toxic Optic Neuropathy 09/2007
1	Necrosis 09/2007

Drug/Important Bio-Agent (IBA)

5	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 06/2017 - 09/2007
4	Ophthalmic Solutions (Eye Drops)IBA 01/2017 - 06/2011
3	Retinaldehyde (Retinal)IBA 03/2022 - 09/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2017 - 01/2008
2	Travoprost (Travatan)FDA Link 01/2008 - 09/2007
2	Latanoprost (Xalatan)FDA Link 01/2008 - 09/2007
1	Messenger RNA (mRNA)IBA 03/2022
1	Fibronectins (Fibronectin)IBA 03/2022
1	Neuroprotective AgentsIBA 09/2015
1	Zonula Occludens-1 ProteinIBA 06/2011
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2011
1	OccludinIBA 06/2011
1	HCEIBA 06/2011
1	Chemokine ReceptorsIBA 01/2008
1	Antiglaucoma AgentsIBA 01/2008
1	Bimatoprost (Lumigan)FDA Link 01/2008
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2008
1	Histocompatibility Antigens Class IIIBA 01/2008

Therapy/Procedure

1	Therapeutics 09/2015
1	Cautery 09/2015